Literature DB >> 33848333

Multiplexing mutation rate assessment: determining pathogenicity of Msh2 variants in Saccharomyces cerevisiae.

Anja R Ollodart1,2, Chiann-Ling C Yeh2, Aaron W Miller2, Brian H Shirts3, Adam S Gordon4, Maitreya J Dunham2.   

Abstract

Despite the fundamental importance of mutation rate as a driving force in evolution and disease risk, common methods to assay mutation rate are time-consuming and tedious. Established methods such as fluctuation tests and mutation accumulation experiments are low-throughput and often require significant optimization to ensure accuracy. We established a new method to determine the mutation rate of many strains simultaneously by tracking mutation events in a chemostat continuous culture device and applying deep sequencing to link mutations to alleles of a DNA-repair gene. We applied this method to assay the mutation rate of hundreds of Saccharomyces cerevisiae strains carrying mutations in the gene encoding Msh2, a DNA repair enzyme in the mismatch repair pathway. Loss-of-function mutations in MSH2 are associated with hereditary nonpolyposis colorectal cancer, an inherited disorder that increases risk for many different cancers. However, the vast majority of MSH2 variants found in human populations have insufficient evidence to be classified as either pathogenic or benign. We first benchmarked our method against Luria-Delbrück fluctuation tests using a collection of published MSH2 missense variants. Our pooled screen successfully identified previously characterized nonfunctional alleles as high mutators. We then created an additional 185 human missense variants in the yeast ortholog, including both characterized and uncharacterized alleles curated from ClinVar and other clinical testing data. In a set of alleles of known pathogenicity, our assay recapitulated ClinVar's classification; we then estimated pathogenicity for 157 variants classified as uncertain or conflicting reports of significance. This method is capable of studying the mutation rate of many microbial species and can be applied to problems ranging from the generation of high-fidelity polymerases to measuring the frequency of antibiotic resistance emergence.
© The Author(s) 2021. Published by Oxford University Press on behalf of Genetics Society of America. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  MSH2; chemostat; mutation rate; yeast

Mesh:

Substances:

Year:  2021        PMID: 33848333      PMCID: PMC8225350          DOI: 10.1093/genetics/iyab058

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  63 in total

1.  MUSCLE: multiple sequence alignment with high accuracy and high throughput.

Authors:  Robert C Edgar
Journal:  Nucleic Acids Res       Date:  2004-03-19       Impact factor: 16.971

2.  The distribution of the numbers of mutants in bacterial populations.

Authors:  D E LEA; C A COULSON
Journal:  J Genet       Date:  1949-12       Impact factor: 1.166

3.  Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair.

Authors:  M Strand; T A Prolla; R M Liskay; T D Petes
Journal:  Nature       Date:  1993-09-16       Impact factor: 49.962

4.  Mutator phenotypes of common polymorphisms and missense mutations in MSH2.

Authors:  K Drotschmann; A B Clark; T A Kunkel
Journal:  Curr Biol       Date:  1999-08-26       Impact factor: 10.834

5.  Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome.

Authors:  Delphine Bouvet; Sahra Bodo; Annie Munier; Erell Guillerm; Romane Bertrand; Chrystelle Colas; Alex Duval; Florence Coulet; Martine Muleris
Journal:  Gastroenterology       Date:  2019-04-15       Impact factor: 22.682

Review 6.  The enduring utility of continuous culturing in experimental evolution.

Authors:  David Gresham; Maitreya J Dunham
Journal:  Genomics       Date:  2014-10-02       Impact factor: 5.736

7.  Suspected Lynch syndrome associated MSH6 variants: A functional assay to determine their pathogenicity.

Authors:  Hellen Houlleberghs; Anne Goverde; Jarnick Lusseveld; Marleen Dekker; Marco J Bruno; Fred H Menko; Arjen R Mensenkamp; Manon C W Spaander; Anja Wagner; Robert M W Hofstra; Hein Te Riele
Journal:  PLoS Genet       Date:  2017-05-22       Impact factor: 5.917

8.  The Genetic Basis of Mutation Rate Variation in Yeast.

Authors:  Liangke Gou; Joshua S Bloom; Leonid Kruglyak
Journal:  Genetics       Date:  2018-11-30       Impact factor: 4.562

9.  Computational and cellular studies reveal structural destabilization and degradation of MLH1 variants in Lynch syndrome.

Authors:  Amanda B Abildgaard; Amelie Stein; Sofie V Nielsen; Katrine Schultz-Knudsen; Elena Papaleo; Amruta Shrikhande; Eva R Hoffmann; Inge Bernstein; Anne-Marie Gerdes; Masanobu Takahashi; Chikashi Ishioka; Kresten Lindorff-Larsen; Rasmus Hartmann-Petersen
Journal:  Elife       Date:  2019-11-07       Impact factor: 8.140

10.  Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast.

Authors:  Matjaz Vogelsang; Aleksandra Comino; Neja Zupanec; Petra Hudler; Radovan Komel
Journal:  BMC Cancer       Date:  2009-10-28       Impact factor: 4.430

View more
  1 in total

1.  PacRAT: a program to improve barcode-variant mapping from PacBio long reads using multiple sequence alignment.

Authors:  Chiann-Ling C Yeh; Clara J Amorosi; Soyeon Showman; Maitreya J Dunham
Journal:  Bioinformatics       Date:  2022-05-13       Impact factor: 6.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.